NDC properties for "24 HR Androderm 0.0833 MG/HR Transdermal System" (RxCUI 1190955)
About this data
The tables show NDC propoerties for 24 HR Androderm 0.0833 MG/HR Transdermal System with the RxCUI 1190955
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for 24 HR Androderm 0.0833 MG/HR Transdermal System (RxCUI 1190955)
MMSL_CODE | BD39855 |
---|---|
RxCUI | 1190955 |
Prescribable Synonym | ANDRODERM 2 MG/Day 24HR Transdermal System |
RXNAV_STR | ANDRODERM 2 MG/Day 24HR Transdermal System |
RxNorm Name | 24 HR testosterone 0.0833 MG/HR Transdermal System [Androderm] |
RxNorm Synonym | 24 HR Androderm 0.0833 MG/HR Transdermal System |
RxNorm Synonym | Androderm 2 MG per 24 HR Transdermal Patch |
RxNorm Synonym | ANDRODERM 2 MG/Day 24HR Transdermal System |
Related queries | Interactions (for RxCUI 1190955) |
NDC Properties
NDC Item 00023599002
NDC 9 | 0023-5990 |
---|---|
NDC 10 | 0023-5990-02 |
NDC Item | 00023599002 |
DCSA | CIII |
FDA SPL set id | 692017 |
Labeler | Allergan, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2024-09-30 |
Marketing effective time low | 1995-09-29 |
Marketing status | COMPLETED |
NDA | NDA020489 |
Related queries | Properties for NDC 9 0023-5990 |
NDC Item 00023599060
NDC 9 | 0023-5990 |
---|---|
NDC 10 | 0023-5990-60 |
NDC Item | 00023599060 |
Packaging | 60 POUCH in 1 CARTON (0023-5990-60) / 1 PATCH in 1 POUCH / 1 d in 1 PATCH |
DCSA | CIII |
FDA SPL set id | 692017 |
Labeler | Allergan, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2024-09-30 |
Marketing effective time low | 1995-09-29 |
Marketing status | COMPLETED |
NDA | NDA020489 |
Related queries | Properties for NDC 9 0023-5990 |
NDC Item 00023599002
NDC 9 | 0023-5990 |
---|---|
NDC 10 | 0023-5990-02 |
NDC Item | 00023599002 |
DCSA | CIII |
FDA SPL set id | 692017 |
Labeler | Allergan, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2024-09-30 |
Marketing effective time low | 1995-09-29 |
Marketing status | COMPLETED |
NDA | NDA020489 |
Related queries | Properties for NDC 9 0023-5990 |
NDC Item 00023599060
NDC 9 | 0023-5990 |
---|---|
NDC 10 | 0023-5990-60 |
NDC Item | 00023599060 |
Packaging | 60 POUCH in 1 CARTON (0023-5990-60) / 1 PATCH in 1 POUCH / 1 d in 1 PATCH |
DCSA | CIII |
FDA SPL set id | 692017 |
Labeler | Allergan, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2024-09-30 |
Marketing effective time low | 1995-09-29 |
Marketing status | COMPLETED |
NDA | NDA020489 |
Related queries | Properties for NDC 9 0023-5990 |